Allianz reports progress toward full-year targets after strong performance

Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) Allianz SE
Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) - Allianz SE
0Comments

Allianz SE has announced that it is on track to meet its full-year ambitions, citing strong performance in recent months. The company, which operates in nearly 70 countries, serves both private and corporate customers with a wide range of insurance products including property, life, health, assistance services, credit insurance, and global business insurance.

Fabrizio Tolotti from Allianz SE stated: “The Allianz Group is one of the world’s leading insurers and asset managers serving private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 749 billion euros* on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.8 trillion euros* of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2024, over 156,000 employees achieved total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros for the Group.”

As of June 30, 2025, Allianz manages approximately 749 billion euros for its insurance clients while PIMCO and Allianz Global Investors handle around 1.8 trillion euros in third-party assets. In 2024, the company reported a total business volume of nearly 180 billion euros with an operating profit reaching 16 billion euros.

Allianz continues to integrate environmental and social considerations into its operations and investment decisions—a practice that has contributed to its standing as a leader within sustainability indices such as the Dow Jones Sustainability Index.

The company’s next financial results are scheduled for release on November 14, 2025.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.